Tag

Hepatitis B

All articles tagged with #hepatitis b

politics53 minutes ago

Vaccines at the Center as Surgeon General Nominee Faces Senate Scrutiny

At a Senate confirmation hearing, Casey Means, President Trump’s surgeon general nominee, was grilled over vaccines and the autism link, refused to push universal vaccination, and urged parents to discuss shots with doctors while acknowledging vaccines’ life-saving role and supporting shared clinical decision-making; lawmakers pressed on universal hepatitis B birth-dose policy and Means’s credentials, including her inactive medical license and wellness-influencer background.

New Documents Trace Controversial Hepatitis B Birth-Dose Study's Shortcut to CDC Approval
politics5 days ago

New Documents Trace Controversial Hepatitis B Birth-Dose Study's Shortcut to CDC Approval

A Rolling Stone investigation shows that a $1.6 million birth-dose hepatitis B vaccine study in Guinea-Bissau was moved directly from the CDC director’s office to grants management, bypassing normal scientific review and ethical oversight, amid pressure from Kennedy allies and irregular ethics approvals, drawing WHO concern and congressional scrutiny as the project remains in limbo.

WHO flags unethical US-backed newborn hepatitis B trial in Guinea-Bissau
health11 days ago

WHO flags unethical US-backed newborn hepatitis B trial in Guinea-Bissau

The World Health Organization criticized and halted a US-funded hepatitis B vaccine trial in Guinea-Bissau that would compare vaccinating newborns at birth with delaying the dose to six weeks, calling the plan unethical and lacking justified scientific safeguards; the birth dose is a proven public health intervention, and about 14,000 babies were to be enrolled before the government suspended the project amid public outrage. Guinea-Bissau plans to roll out the birth-dose nationwide by 2028, with WHO support to accelerate adoption.

Africa CDC Defends Sovereignty Over US-Backed Infant Vaccine Trial
world1 month ago

Africa CDC Defends Sovereignty Over US-Backed Infant Vaccine Trial

Africa CDC chief Jean Kaseya rebuked a US-backed plan to run an infant hepatitis B vaccine trial in Guinea-Bissau, insisting any study must be authorized by Guinea-Bissau’s National Medicines Regulatory Authority, National Ethics Committee, local IRBs, and the Ministry of Health, underscoring Africa’s sovereignty. The proposed trial would have enrolled about 14,000 newborns (7,000 vaccinated, 7,000 controls) and was funded with $1.6 million from the US HHS. Critics say such research should serve Africans’ needs and ensure standard care for controls, while the US has criticized Africa CDC as “fake and powerless.” The flare-up exposes tensions between Western funders and African health authorities over governance of research.

Guinea-Bissau halts US-funded birth-dose hepatitis B trial amid ethics concerns
world1 month ago

Guinea-Bissau halts US-funded birth-dose hepatitis B trial amid ethics concerns

Guinea-Bissau suspended a US-funded hepatitis B vaccine trial that would randomize about 14,000 newborns to receive a birth dose or not, pending a technical and ethical review by the national public health institute. The Bandim Health Project designed the study and it received a $1.6 million CDC grant, with the goal of evaluating broader vaccine effects ahead of the country’s planned universal birth-dose policy in 2027. While the US Health and Human Services says the trial remains on track, African scientists have questioned funding-driven dynamics and governance, arguing the design could undermine safe vaccination or reflect political pressure to limit vaccines in Africa. The dispute highlights ongoing tensions over who controls clinical research in Africa and how local health priorities are weighed against external funding interests.

CDC Reverses Universal Hepatitis B Vaccine Recommendation for Newborns
health2 months ago

CDC Reverses Universal Hepatitis B Vaccine Recommendation for Newborns

The CDC has officially stopped recommending universal hepatitis B vaccination for all newborns, instead advising only those born to infected mothers to receive the vaccine within 24 hours, citing informed consent concerns. This decision has faced criticism from health experts who warn it could lead to increased hepatitis B cases, reversing decades of progress in disease prevention. The change reflects broader shifts in CDC guidance under new leadership, raising concerns about scientific integrity and public health safety.

Debate Continues Over Hepatitis B Vaccination Policies and CDC's Role
health2 months ago

Debate Continues Over Hepatitis B Vaccination Policies and CDC's Role

RFK Jr. has criticized the CDC, leading to a decline in trust and changes in vaccination policies, including a recommendation to limit Hepatitis B shots for newborns, despite extensive evidence supporting vaccine safety and effectiveness. His actions and claims have been widely condemned by health experts and lawmakers, raising concerns about misinformation impacting public health efforts.

Controversy Surrounds Hepatitis B Vaccine and CDC Decisions
health2 months ago

Controversy Surrounds Hepatitis B Vaccine and CDC Decisions

A federal vaccine advisory committee is considering changing the recommendation for hepatitis B vaccination in newborns, which has been a public health success in reducing infections. The move has sparked debate due to concerns about safety, trust, and potential increases in hepatitis B cases if delayed, with many health organizations advocating to continue the current practice of vaccinating at birth.